![]() |
市場調查報告書
商品編碼
1496025
全球皮下注射針市場:2024-2029 年預測Global Hypodermic Needle Market - Forecasts from 2024 to 2029 |
預計在預測期內,皮下注射針市場將以 6.42% 的年複合成長率成長,市場規模將從 2022 年的 3,034,881,000 美元達到 2029 年的 4,690,217,000 美元。
皮下注射針是一種醫療器械,用於通常透過皮下、肌肉或靜脈注射將物質注射到體內或從體內提取液體。皮下注射針由一根帶有鋒利尖端的中空圓形空管和柱塞組成,可以精確組織藥物、疫苗接種以及血液和其他液體的抽取。
全球皮下注射針廣告涉及醫療保健行業使用的皮下注射針的製造、分銷和銷售。市場的主要觀點包括安全針頭、非安全針頭、應用程式、最終用戶、地理接近性、管理環境、未使用的改進、行業主要參與者和開放的福利活動。安全針頭著重醫護人員安全等方面,降低針刺傷害的風險。
非安全針是沒有額外安全部件的傳統針。全球皮下注射針市場充滿活力,並受到創新進步、醫療保健方法以及需要在恢復性醫療干預中使用皮下注射針的疾病流行等因素的影響。
由於全球糖尿病盛行率不斷上升,預計該市場將在未來幾年獲得成長動力。根據國際糖尿病聯盟提供的資訊,到2021年,大約有5.37億20歲至79歲年齡層的成年人將患有糖尿病多年。此外,預計到 2030 年,糖尿病患者人數將增至 6.43 億,到 2045 年將增至 7.83 億。
全球糖尿病支出的增加預計將大幅增加先進藥物輸送解決方案的採用。許多公司和企業正在為糖尿病患者提供先進和新穎的解決方案,例如將針插入患者體內來輕鬆輸送藥物。
近年來,一些公司和企業對市場產生了重大影響。隨著公司傾向提高其競爭優勢和全球整體市場佔有率,預計未來幾年研發支出將大幅增加。 Iskcon Surgicals 是該市場的主要企業之一,向其客戶供應和銷售一次性皮下注射針。
該公司表示,其針頭採用高精度拋光、矽化和超音波清洗技術製造。該公司的產品已通過ISO認證。其他公司也為其客戶提供先進的皮下注射針。
例如,NIPRO 是最大的針製造商之一,每年生產約 110 億支針。該公司聲明其產品並非以 PVC 或乳膠形式製造。該公司還提供各種長度和尺寸的皮下注射針。這些新興市場的開拓和趨勢預計將在預測期內在市場中發揮重要作用。
由於全球氣喘盛行率不斷上升,皮下注射針的使用預計將在預測期內急劇增加。根據世界衛生組織(WHO)資訊顯示,氣喘進一步被納入世界衛生組織《預防和控制非傳染性疾病(NCD)全球行動計畫》和聯合國2030年永續發展計畫。
世衛組織也採取多項措施改善低收入和中等收入國家的藥品運輸。隨著工業化的擴大,人們對高污染的擔憂,這是導致氣喘患者盛行率增加的主要因素之一。因此,我們預計在預測期內皮下注射針和其他藥物輸送產品的採用將會增加。
由於全球慢性感染疾病的流行,該行業預計將激增。預計這種成長將推動針頭和注射器的採用,它們似乎能夠可靠地將藥物輸送到身體系統。此外,疫苗接種率的提高預計也將推動全球對新注射劑的需求。
多種糖尿病和氣喘患者使用皮下注射針。這些患者需要對藥物和液體脫敏,以防特定的不良反應。世界各國政府都制定了指令和法律,允許患者攜帶皮下注射針而不受重大限制。例如,2021 年 3 月,美國馬裡蘭州參議院報告通過了一項新法案,將分發和擁有皮下注射針合法化。
此外,2021 年 10 月,紐約州政府報告稱通過了一項法案,該法案將使該州皮下注射針的分銷和銷售合法化。根據這項新法案,皮下注射針將不再被視為醫療器材。政府表示,引入新立法是為了讓人們更容易使用藥物傳輸系統。
The global hypodermic needle market is expected to grow at a compound annual growth rate of 6.42% over the forecast period to reach a market size of US$4,690.217 million in 2029, from US$3,034.881 million in 2022.
A hypodermic needle is a medical instrument utilized for infusing substances or extricating liquids from the body, ordinarily through subcutaneous, intramuscular, or intravenous courses. It comprises a hollow, round, and empty tube with a sharp tip and plunger, permitting for exact organization of drugs, immunizations, or withdrawal of blood or other liquids.
The worldwide hypodermic needle advertise includes the manufacturing, distribution, and selling of hypodermic needles utilized within the healthcare industry. Key viewpoints of the market include safety needles, non-safety needles, applications, end-users, geographical nearness, administrative environment, unused improvements, industry key players, and open well-being activities. Safety needles focus on aspects like healthcare employee safety, lessening the hazard of needlestick wounds.
Non-safety needles are conventional needles without extra security components. The worldwide hypodermic needle market is energetic and affected by components such as innovative headways, healthcare approaches, and the predominance of maladies that require the utilize of hypodermic needles in restorative medical intercessions.
The market is predicted to experience a boost in the years ahead due to the increase in the prevalence rate of diabetes around the world. According to the information provided by the International Diabetes Federation, around 537 million adult individuals have been living with diabetes for years, between the ages of 20 and 79 category in the year 2021. Further, it has also been estimated that the global population living with diabetes is expected to grow to 643 million by 2030 and around 783 million by 2045.
Increasing global expenditure on diabetes has been expected to surge the adoption of advanced drug delivery solutions. Various companies and corporations have been offering advanced and novel solutions for diabetic patients, such as the easy delivery of drugs by needles in a patient's body.
Several firms and corporations have been making a considerable impact in the market in the past few years. The increasing expenditure on research and development was expected to surge in the next few years as corporations tend to increase their competitive advantage and overall market share globally. Iscon Surgicals Ltd., one of the key players in the market, has been providing and selling disposable hypodermic needles to its customers.
The company stated that its needle had been produced through high and advanced precision grinding, siliconization, and ultrasonic cleaning. The company's products are ISO Certified. Other corporations have been offering advanced hypodermic needles for their customers.
For instance, NIPRO, one of the largest needle manufacturers, produces around 11 billion units annually. The company stated that its products are not manufactured as PVC or latex. It also offers hypodermic needles in different lengths and sizes. These developments and trends are expected to play a significant role in the market during the forecast period.
Hypodermic needle utilization is anticipated to surge within the projected period due to the expanding rate of asthma, around the world. According to the information given by the World Wellbeing Organisation (WHO), asthma is additionally included in the WHO Worldwide Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) and the United Nations 2030 Plan for Sustainable Development.
The WHO has also been undertaking a few measures to upgrade the drug conveyance segment in lower and middle-income nations. With expanding industrialization, there has been a concern around high contamination, which has been one of the major components of the expanding prevalence rate of asthmatic patients. Subsequently, it is anticipated to improve the adoption of hypodermic needles and other drug-delivery products within the projected time period.
The industry is anticipated to surge due to the rise in the predominance rate of chronic infections around the world. This increment is anticipated to boost the adoption of needles and syringes that seem to securely deliver drugs into the body system. Moreover, increasing vaccination rates were also expected to enhance the demand for novel injectable solutions, worldwide.
Various patients living with diabetes and asthma condition have been utilizing hypodermic needles on their own. These patients needed to desensitize drugs and infusions in case of distinctive unfavorably susceptible reactions. Governments around the world have been facilitating the directions and laws that permit patients to carry hypodermic needles without any major confinements. For example, in March 2021, the Maryland Senate in the United States reported the passing of a novel bill decriminalizing the dispersion and ownership of hypodermic needles.
In addition, in October 2021, the New York Government reported the passing of a bill decriminalizing the distribution and sales of hypodermic needles within the state. Beneath this novel bill, hypodermic needles would not be considered as medicate gear. The government stated that the novel bill had been introduced to enhance the accessibility of the drug delivery systems to the people.